Research Article

Bakuchiol Alleviates Hyperglycemia-Induced Diabetic Cardiomyopathy by Reducing Myocardial Oxidative Stress via Activating the SIRT1/Nrf2 Signaling Pathway

Figure 9

BAK treatment increased cell viability, raised intracellular SIRT1 expression and activity, and enhanced Nrf2 nuclear accumulation in HG-treated H9c2 cells. (a) BAK treatment (2 μM, 5 μM, and 10 μM) had no toxic effect on the cell viability of control H9c2 cells. (b) BAK treatment dose dependently increased the cell viability in HG-treated H9c2 cells. (c) Representative blots. (d) SIRT1 expression. (e) Relative SIRT1 activity. (f) Nrf2 nuclear translocation. Data are presented as the ( in each group). aa vs. the control group, bb vs. the HG group, cc vs. the HG+BAK group, and dd vs. the siSIRT1+HG+BAK group.
(a)
(b)
(c)
(d)
(e)
(f)